Articles By Anuja Singh
How Did Novartis Navigate 2025 and What’s Ahead for 2026?
In 2025, Novartis demonstrated resilience and strategic focus, balancing strong performance in its core franchises with investments in…
ByHow Did AbbVie’s 2025 Deals Shape Its Year, and What Do They Signal for…
NORTH CHICAGO, IL — As 2025 concludes, AbbVie Inc. reflects on a year of strategic dealmaking that complements…
Did AbbVie Successfully Manage 2025 Headwinds, and Are Rinvoq and Skyrizi Poised to Reach…
NORTH CHICAGO, ILLINOIS — As 2025 comes to a close, AbbVie reflects on a year marked by strong…
Is Lilly Shaping Its Post-Blockbuster Future Through Verve, Superluminal, and AI-Driven Partnerships in 2025?
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster brands driving growth…
Is Lilly Strengthening Its 2026 Growth Outlook by Scaling Zepbound, Mounjaro, and Its Core…
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a focused strategy centered…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping the Company’s Next Phase
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at strengthening its pipeline,…
How Did Novartis Navigate 2025 and What’s Ahead for 2026?
In 2025, Novartis demonstrated resilience and strategic focus, balancing strong performance in its core franchises with investments in…
How Did AbbVie’s 2025 Deals Shape Its Year, and What Do They Signal for…
NORTH CHICAGO, IL — As 2025 concludes, AbbVie Inc. reflects on a year of strategic dealmaking that complements…
Did AbbVie Successfully Manage 2025 Headwinds, and Are Rinvoq and Skyrizi Poised to Reach…
NORTH CHICAGO, ILLINOIS — As 2025 comes to a close, AbbVie reflects on a year marked by strong…
Is Lilly Shaping Its Post-Blockbuster Future Through Verve, Superluminal, and AI-Driven Partnerships in 2025?
In 2025, Eli Lilly and Company approached dealmaking from a position of strength. With blockbuster brands driving growth…
Is Lilly Strengthening Its 2026 Growth Outlook by Scaling Zepbound, Mounjaro, and Its Core…
In 2025, Eli Lilly and Company continued to build on its strong momentum, executing a focused strategy centered…
Pfizer’s Strategic Deals in 2025: Key Moves Shaping the Company’s Next Phase
Strategic Takeaways In 2025, Pfizer executed a series of focused and strategic deals aimed at strengthening its pipeline,…